
Chapter 7: Functional description
Fresenius Medical Care multiFiltrate IFU-EN-UK 15A-2015
7-9
13
Substituate pump
14
Scale 2
15
Substituate
16
Heater
17
Dialysate pump
18
Scale 1
19
Dialysate
Treatment parameters
Efficacy of CRRT
treatments
The efficacy of CRRT treatments depends largely on the total volume of
formed filtrate.
Effluent
In practice, the efficacy is determined by the applied volume or the
selected flows of substituate and dialysate. With the Pre CVVHDF,
Post CVVHDF, and Pre-Post CVVH combined treatments, the total
dose is distributed to both pumps that are used (e.g., the intended total
dose in Post CVVHDF 2000 ml/h is applied as 1000 ml/h substitution in
postdilution and 1000 ml/h dialysate).
It may be necessary to increase the prescribed total dose in treatments
with predilution to compensate for the reduction of efficacy caused by
predilution (see above).
Depending on the filter used, a reduction of the middle-molecular
clearance is possible if dialysate is used (see above).
Coagulation risk in CRRT
treatments
The risk of coagulation in the extracorporeal blood circuit is different in
the individual CRRT treatments.
With postdilution, there is a haemoconcentration of the blood at the filter
outlet, depending on the ratio of the filtrate flow to the blood flow, and
on the patient's haematocrit. This is assumed to be the reason for the
shorter operating lives of the filters in Post CVVH compared to
Pre CVVH.
There is evidence that the coagulation activity is lower in dialysis than
in haemofiltration in predilution. It was revealed that the filter operating
lives are significantly longer in CVVHD than in Pre-Post CVVH, even if
the limitation of the filtration fraction to 20% in Pre-Post CVVH was
observed.
CVVHDF
Min.
Max.
Resolution
Unit
Blood flow
10
500
10
ml/min
Ultrafiltration
Off / 10
1200
10
ml/h
UF goal
Off / 50
10,000
50
ml
Cont. heparin adm.
Off / 0.1
25
0.1
ml/h
Substituate
Off / 600
4800
50
ml/h
Dialysate
Off / 600
4800
50
ml/h
Temperature
Off / 35
39
0.5
°C
Содержание multiFiltrate
Страница 1: ...multiFiltrate Instructions for Use Software version 5 3 Edition 15A 2015 Part no M56 963 1 ...
Страница 2: ......
Страница 11: ...Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 xi 15 2 Instructions on the use of free software 15 2 ...
Страница 12: ...xii Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 16: ...Chapter 1 Index 1 4 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 42: ...Chapter 3 Design 3 10 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 166: ...Chapter 4 Operation 4 124 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 Interrupting the treatment ...
Страница 186: ...Chapter 5 Alarm processing 5 20 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 188: ...Chapter 6 Cleaning disinfection 6 2 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 218: ...Chapter 7 Functional description 7 30 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 228: ...Chapter 9 Installation 9 4 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 234: ...Chapter 11 Technical Safety Checks maintenance procedures 11 2 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 252: ...Chapter 12 Specifications 12 18 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 260: ...Chapter 13 Definitions 13 8 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 266: ...Chapter 14 Options 14 6 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...
Страница 282: ...Chapter 15 Appendix 15 16 Fresenius Medical Care multiFiltrate IFU EN UK 15A 2015 ...